keyword
https://read.qxmd.com/read/38051641/joint-meeting-saic-sab-aafe-aacytal-2023
#1
Isabel A Lüthy, Silvina Pérez Martínez, Ventura Simonovich, Gabriel Pinto
No abstract text is available yet for this article.
November 2023: Medicina
https://read.qxmd.com/read/37717633/a-nephrogenic-mechanism-underlies-dexmedetomidine-induced-polyuria-a-case-report
#2
L Vaz Rodrigues, D Roriz, F Salgado-Seixas, S Marinho, P R Ferreira
Dexmedetomidine's α-adrenoreceptor agonism has been gaining popularity in the anesthetic room as a sedative-hypnotic and analgesic agent, and with extensive perioperative use rising concern about side effects is necessary. Bradycardia and hypotension are common adverse effects, but there are also several reports of excessive urine output, possibly due to vasopressin secretion and permeability of collecting ducts. Polyuria usually resolves with discontinuation of the drug, and significant morbidity has not been reported...
September 16, 2023: Revista española de anestesiología y reanimación
https://read.qxmd.com/read/36707309/-translated-article-efficacy-and-marginal-cost-of-treatment-with-tocilizumab-in-covid-19-patients
#3
JOURNAL ARTICLE
A Garcia-Molina, M Alos-Almiñana
OBJECTIVE: To describe the marginal cost and survival of patients treated with tocilizumab in a university hospital under real-life conditions and to evaluate factors that could influence costs and health outcomes will be evaluated. METHODS: Observational, single-center, retrospective study of a cohort of adult patients infected with SARS-COV2 treated with tocilizumab. The 1 year restricted mean survival time was analyzed in life-years gained (LYG). The influence of sex, age and severity on patient survival was evaluated...
December 28, 2022: Farmacia Hospitalaria
https://read.qxmd.com/read/36635189/efficacy-and-marginal-cost-of-treatment-with-tocilizumab-in-covid-19-patients
#4
JOURNAL ARTICLE
Antonio Garcia-Molina, Manuel Alós-Almiñana
OBJECTIVE: To describe the marginal cost and survival of patients treated with tocilizumab in a university hospital under real-life conditions and to evaluate factors that could influence costs and health outcomes will be evaluated. METHODS: Observational, single-center, retrospective study of a cohort of adult patients infected with SARS-CoV-2 treated with tocilizumab. The one-year restricted mean survival time was analyzed in life-years gained (LYG). The influence of sex, age and severity on patient survival was evaluated...
December 15, 2022: Farmacia Hospitalaria
https://read.qxmd.com/read/34878408/annual-meeting-of-bioscience-societies-2021
#5
Alejandro Curino, Mariana Maccioni, Paula Schaiquevich, Hebe Durán
No abstract text is available yet for this article.
November 2021: Medicina
https://read.qxmd.com/read/34020401/early-prediction-of-pancreatic-cancer-from-new-onset-diabetes-an-associazione-italiana-oncologia-medica-aiom-associazione-medici-diabetologi-amd-societ%C3%A3-italiana-endocrinologia-sie-societ%C3%A3-italiana-farmacologia-sif-multidisciplinary-consensus-position-paper
#6
REVIEW
M Gallo, V Adinolfi, L Morviducci, S Acquati, E Tuveri, P Ferrari, M C Zatelli, A Faggiano, A Argentiero, A Natalicchio, S D'Oronzo, R Danesi, S Gori, A Russo, M Montagnani, G D Beretta, P Di Bartolo, N Silvestris, F Giorgino
Pancreatic cancer (PC) is a common cause of cancer-related death, due to difficulties in detecting early-stage disease, to its aggressive behaviour, and to poor response to systemic therapy. Therefore, developing strategies for early diagnosis of resectable PC is critical for improving survival. Diabetes mellitus is another major public health problem worldwide. Furthermore, diabetes can represent both a risk factor and a consequence of PC: nowadays, the relationship between these two diseases is considered a high priority for research...
May 18, 2021: ESMO Open
https://read.qxmd.com/read/33992527/-liposomal-amphotericin-b-clinical-pharmacology-pharmacokinetics-and-pharmacodynamics
#7
JOURNAL ARTICLE
José Ramón Azanza Perea
Liposomal amphotericin B is a lipid formulation of the antifungal drug amphotericin B with some distinguishing characteristics in its pharmacological behavior that entail some clinical differences of great interest. The significant improvement in the systemic and renal tolerability is one of them. This fact is related to the great stability of the liposome, promoted by its negative charge, the presence of cholesterol and the remarkable thermo-stability of the remaining lipids that compose it. In this situation, amphotericin B seems to be released from the liposome not spontaneously but when the liposome binds to the ergosterol in the fungal cell membrane...
April 2021: Revista Iberoamericana de Micología
https://read.qxmd.com/read/33984679/antineoplastic-dosing-in-overweight-and-obese-cancer-patients-an-associazione-italiana-oncologia-medica-aiom-associazione-medici-diabetologi-amd-societ%C3%A3-italiana-endocrinologia-sie-societ%C3%A3-italiana-farmacologia-sif-multidisciplinary-consensus-position-paper
#8
REVIEW
N Silvestris, A Argentiero, A Natalicchio, S D'Oronzo, G D Beretta, S Acquati, V Adinolfi, P Di Bartolo, R Danesi, A Faggiano, P Ferrari, M Gallo, S Gori, L Morviducci, A Russo, E Tuveri, M C Zatelli, M Montagnani, F Giorgino
Most anticancer molecules are administered in body-size-based dosing schedules, bringing up unsolved issues regarding pharmacokinetic data in heavy patients. The worldwide spread of obesity has not been matched by improved methods and strategies for tailored drug dosage in this population. The weight or body surface area (BSA)-based approaches may fail to fully reflect the complexity of the anthropometric features besides obesity in cancer patients suffering from sarcopenia. Likewise, there is a lack of pharmacokinetic data on obese patients for the majority of chemotherapeutic agents as well as for new target drugs and immunotherapy...
June 2021: ESMO Open
https://read.qxmd.com/read/33528366/-literature-review-on-phyto-therapeutics-for-the-treatment-of-bovine-mastitis
#9
REVIEW
G Fuchs, O J Glardon
Literature review on phyto-therapeutics for the treatment of bovine mastitis.
January 2021: Schweizer Archiv Für Tierheilkunde
https://read.qxmd.com/read/32853883/management-of-metabolic-adverse-events-of-targeted-therapies-and-immune-checkpoint-inhibitors-in-cancer-patients-an-associazione-italiana-oncologia-medica-aiom-associazione-medici-diabetologi-amd-societ%C3%A3-italiana-farmacologia-sif-multidisciplinary-consensus
#10
REVIEW
Nicola Silvestris, Antonella Argentiero, Giordano Domenico Beretta, Paolo Di Bartolo, Monica Montagnani, Romano Danesi, Pietro Ferrari, Stella D'Oronzo, Stefania Gori, Antonio Russo, Silvia Acquati, Marco Gallo
The growing insights in the next-generation immunotherapy and the state-of-the-art advancement in targeted-agents significantly improved clinical outcome of cancer patients by pointing towards a unexplored Achilles' heel. Novel toxicity profiles have been uncovered, representing unmet medical needs. Thus, a panel of expert provide comprehensive pharmacological and clinical evidence, to provide a patient-tailored approach to metabolic adverse events associated with novel anti-cancer treatments. Prompted by the need of a multidisciplinary cooperation, a working group of Associazione Italiana Oncologia Medica (AIOM), Associazione Medici Diabetologi (AMD) and Società Italiana Farmacologia (SIF) examined the available literature data...
October 2020: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/23548008/joint-position-statement-by-%C3%A2-sociedad-espa%C3%A3-ola-de-patolog%C3%A3-a-digestiva%C3%A2-spanish-society-of-gastroenterology-and-%C3%A2-sociedad-espa%C3%A3-ola-de-farmacolog%C3%A3-a%C3%A2-spanish-society-of-pharmacology-on-biosimilar-therapy-for-inflammatory-bowel-disease
#11
JOURNAL ARTICLE
Federico Argüelles-Arias, Manuel Barreiro-de-Acosta, Fernando Carballo, Joaquín Hinojosa, Teresa Tejerina
Biological drugs or biopharmaceutical products, manufactured with or from living organisms using biotechnology, have represented a therapeutic revolution for the control of inflammatory bowel disease (IBD). At present, in this indication and in our country, only two biological are approved, infliximab (IFX) and adalimumab (ADA), both of them monoclonal antibodies against tumor necrosis factor alpha. Effectiveness data are strong for both therapies, with maximum levels of scientific evidence.The upcoming expiry date for these biologicals´ patents has allowed the potential marketing of so-called biosimilar agents for the IBD indication...
January 2013: Revista Española de Enfermedades Digestivas
https://read.qxmd.com/read/22401737/-changes-in-the-european-normative-of-clinical-trials-ii-towards-a-proportional-and-risk-adapted-regulation
#12
JOURNAL ARTICLE
Cristina Avendaño Solá, Joaquín Delgadillo Duarte, Francisco J de Abajo, Nuria Sanz et al.
No abstract text is available yet for this article.
May 12, 2012: Medicina Clínica
https://read.qxmd.com/read/22401721/-changes-in-the-european-normative-of-clinical-trials-i-a-chance-to-improve-the-paperwork-authorization
#13
JOURNAL ARTICLE
Cristina Avendaño Solá, Joaquín Delgadillo Duarte, Caridad Pontes García, Lourdes Cabrera García
No abstract text is available yet for this article.
April 28, 2012: Medicina Clínica
https://read.qxmd.com/read/18783711/-recommendations-for-antibiotic-monitoring-in-icu-patients
#14
JOURNAL ARTICLE
Francisco Alvarez, Pedro Olaechea, Santiago Grau, Mónica Marín, Alfonso Domínguez, José Martínez-Lanao, Dolors Soy, Manuel Alos, María Victoria, Belén Sádaba, Africa Mediavilla, Daniel Fatela
Monitoring plasma concentrations of antimicrobial agents used to treat infection in critically ill patients is one of the recommended strategies for improving clinical outcome. Drug monitoring has a double aim: to limit adverse events and to increase the effectiveness of the drugs. In clinical practice, however, this approach is mainly limited to monitoring plasma concentrations of vancomycin and aminoglycosides, although future extension to other antimicrobial agents would be desirable. Application of this technique varies considerably between hospitals, and this makes interpretation and comparison of the results obtained difficult...
March 2008: Farmacia Hospitalaria
https://read.qxmd.com/read/12548315/tyrosol-and-hydroxytyrosol-are-absorbed-from-moderate-and-sustained-doses-of-virgin-olive-oil-in-humans
#15
RANDOMIZED CONTROLLED TRIAL
E Miró-Casas, M-I Covas, M Fitó, M Farré-Albadalejo, J Marrugat, R de la Torre
OBJECTIVE: To investigate the absorption of tyrosol and hydroxytyrosol from moderate and sustained doses of virgin olive oil consumption. The study also aimed to investigate whether these phenolic compounds could be used as biomarkers of virgin olive oil intake. DESIGN AND INTERVENTIONS: Ingestion of a single dose of virgin olive oil (50 ml). Thereafter, for a week, participants followed their usual diet which included 25 ml/day of the same virgin olive oil as the source of raw fat...
January 2003: European Journal of Clinical Nutrition
https://read.qxmd.com/read/12525337/-survey-on-the-needs-expressed-by-primary-care-doctors-for-continuing-education-in-drug-therapy
#16
JOURNAL ARTICLE
D Rodríguez, R Llop, M E Barceló, E Cucurull, J A Vallés, E Diogène, N García, E Fernández, N Sabaté, E Simó, J Casadevall
OBJECTIVE: To describe the aspects of continuing education in pharmacological therapeutics considered as most relevant by the primary health care physicians. DESIGN: Observational study.Setting. Physicians filled-up the questionnaires during 45 minutes at their primary health care centres. PARTICIPANTS: Primary health care physicians involved in the Fundation Institut Català de Farmacologia continuing education activities since 1997 were selected...
December 2002: Atencion Primaria
https://read.qxmd.com/read/7212722/-abstracts-of-lectures-symposia-and-communications-presented-at-the-sociedad-de-biolog%C3%A3-a-farmacolog%C3%A3-a-de-chile-sociedad-de-gen%C3%A3-tica-de-chile-26-29-november-1980-vina-del-mar-chile
#17
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
October 1980: Archivos de Biología y Medicina Experimentales
https://read.qxmd.com/read/6680989/-abstracts-of-proceedings-5th-annual-meeting-of-the-sociedad-de-farmacolog%C3%A3-a-de-chile
#18
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 1983: Archivos de Biología y Medicina Experimentales
https://read.qxmd.com/read/6546233/-15th-meeting-of-the-asociaci%C3%A3-n-latinoamericana-de-ciencias-fisiol%C3%A3-gicas-27th-annual-meeting-of-the-sociedad-de-biolog%C3%A3-a-de-chile-6th-annual-meeting-of-the-sociedad-de-farmacolog%C3%A3-a-de-chile-abstracts
#19
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 1984: Archivos de Biología y Medicina Experimentales
https://read.qxmd.com/read/6535614/proceedings-of-the-9th-congress-of-the-sociedade-brasileira-de-biof%C3%A3-sica-2nd-congress-of-the-sociedade-brasileira-de-farmacologia-e-terap%C3%A3%C2%AAutica-experimental-19th-congress-of-the-sociedade-brasileira-de-fisiologia-june-30-july-4-1984-s%C3%A3-o-paulo-abstracts
#20
JOURNAL ARTICLE
keyword
keyword
58273
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.